An Eli Lilly spokesperson told Stateline in a statement that Lilly will continue to pursue legal remedies against those who falsely claim their products are Mounjaro, Zepbound, or FDA-approved tirzepatide, including certain med-spas, wellness centers, online retailers, and compounding pharmacies. Some states are focusing their investigations specifically on medical spas and IV infusion clinics that offer compounded weight-loss medications
never take more medication than is prescribed to you
For more information, contact us or book an appointment online
Hair loss due to GLP-1 Although Ozempic does not list hair loss as a side effect, a clinical trial reported 3% of patients experienced hair loss, compared with 1% in the placebo group
"Despite the fact that an association between semaglutide treatment and NAION was found, current evidence remains insufficient to establish definitive conclusions regarding its association with NAION," the report said